Cholesterol Screening/ Cholesterol Lab Testing Services Market by Type of Customer (Physician/Provider, Hospital, Employer, Health Plan, MCO, Government, ACO, IDN, Patient), Geography (North America, Europe) & Qualitative Assessment - Forecasts to 2021
The global cholesterol testing services market is expected to reach USD 17.5 billion by 2021 from USD 11.9 billion in 2016, growing at a CAGR of 8% during the forecast period. This market is segmented on the basis of type of customer and region. Based on type of customer, the market is segmented into physicians/providers and hospitals; employers, health plans, and Managed Care Organizations (MCOs); government agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs); and patients. Based on region, the cholesterol testing services market is segmented into North America, Europe, Asia, and the Rest of the World (RoW).
Factors such as increasing incidence of cardiovascular diseases and obesity, physician preference of laboratory testing rather self-testing, growing awareness and adoption of preventive healthcare, government initiatives to improve the quality of testing, and rapid growth in the geriatric population are propelling the growth of this market. Moreover, emerging economies and patient-driven testing services are expected to offer high potential for growth during the forecast period. However, rapidly growing home/self-testing and emergence of noninvasive cholesterol testing methods are the major factors that may limit the growth of the market to a certain extent.
In 2016, North America is estimated to account for the largest share of the global cholesterol testing services market. In North America, the U.S. is a major market for cholesterol testing service providers. North America’s dominance in the market can be attributed to the increase in Clinical Laboratory Improvement Amendments (CLIA) waivers for certain diagnostic tests (including blood cholesterol), growing geriatric population, increasing efforts by ACOs for population health management and early disease intervention, and the presence of leading market players in the region.
However, Asia is projected to be the fastest-growing region during the forecast period. Factors such as high population, increased prevalence of cardiovascular diseases, and growing number of testing facilities in the Asian region are driving the growth of this market.
Research Coverage
Apart from comprehensive geographical analysis, service analysis, and market sizing, the report also provides cost structure & pricing analysis, reimbursement scenario, market share analysis and competitive landscape that cover growth strategies adopted by industry players in the last three years. Also, the company profiles comprise basic views on the key players and their product portfolios, core competencies, developments, and strategies adopted. The above-mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding service offerings, geographical focus, changes in strategic approach, cost structure and pricing analysis, R&D investments for innovations in services and technologies and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
Factors such as increasing incidence of cardiovascular diseases and obesity, physician preference of laboratory testing rather self-testing, growing awareness and adoption of preventive healthcare, government initiatives to improve the quality of testing, and rapid growth in the geriatric population are propelling the growth of this market. Moreover, emerging economies and patient-driven testing services are expected to offer high potential for growth during the forecast period. However, rapidly growing home/self-testing and emergence of noninvasive cholesterol testing methods are the major factors that may limit the growth of the market to a certain extent.
In 2016, North America is estimated to account for the largest share of the global cholesterol testing services market. In North America, the U.S. is a major market for cholesterol testing service providers. North America’s dominance in the market can be attributed to the increase in Clinical Laboratory Improvement Amendments (CLIA) waivers for certain diagnostic tests (including blood cholesterol), growing geriatric population, increasing efforts by ACOs for population health management and early disease intervention, and the presence of leading market players in the region.
However, Asia is projected to be the fastest-growing region during the forecast period. Factors such as high population, increased prevalence of cardiovascular diseases, and growing number of testing facilities in the Asian region are driving the growth of this market.
Research Coverage
Apart from comprehensive geographical analysis, service analysis, and market sizing, the report also provides cost structure & pricing analysis, reimbursement scenario, market share analysis and competitive landscape that cover growth strategies adopted by industry players in the last three years. Also, the company profiles comprise basic views on the key players and their product portfolios, core competencies, developments, and strategies adopted. The above-mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding service offerings, geographical focus, changes in strategic approach, cost structure and pricing analysis, R&D investments for innovations in services and technologies and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the service offerings of top players in the cholesterol testing services market. The report analyzes this market by type of customer and region
- Service Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new service launches in the cholesterol testing services market
- Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and service portfolios of the leading players in the cholesterol testing services market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for cholesterol testing services across regions.
- Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the cholesterol testing services market
1. INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET INTRODUCTION
1.3 MARKET DEFINITION
1.4 MARKET SCOPE
1.5 YEARS CONSIDERED FOR THE STUDY
1.6 LIMITATIONS
1.7 STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3 KEY DATA FROM SECONDARY SOURCES
2.4 KEY DATA FROM PRIMARY SOURCES
2.5 ASSUMPTIONS
3. EXECUTIVE SUMMARY
4. PREMIUM INSIGHTS
4.1 MARKET OVERVIEW
4.2 CHOLESTEROL TESTING SERVICES MARKET, BY TYPE OF CUSTOMER
4.3 GEOGRAPHIC SNAPSHOT: CHOLESTEROL TESTING SERVICES MARKET
5. INDUSTRY INSIGHTS
5.1 COST STRUCTURE & PRICING ANALYSIS
5.2 REIMBURSEMENT SCENARIO
6. MARKET DYNAMICS
6.1 INTRODUCTION
6.2 MARKET DRIVERS
6.2.1 Increasing incidence of cardiovascular diseases (CVDs) and obesity
6.2.2 Physician’s preference for lab testing over self-testing
6.2.3 Growing awareness and adoption of preventive healthcare
6.2.4 Government initiatives to improve quality of testing
6.2.5 Rapid growth in the geriatric population
6.2 MARKET RESTRAINTS
6.3.1 Rapidly growing cholesterol home/self-testing market
6.3.2 Emergence of noninvasive cholesterol testing methods
6.3 MARKET OPPORTUNITIES
6.4.1 High growth potential in emerging economies
6.4.2 Patient-initiated testing to foster market growth in developed countries
6.4 MARKET CHALLENGES
6.5.1 Patient data security
6.5.2 Evolving regulatory policies
7. NON-PHARMACOLOGICAL TREATMENT MARKET
6.1 INTRODUCTION
6.1.1 COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA (CBTI)
6.1.2 HYPNOTHERAPY
6.1.3 OTHER ALTERNATIVE THERAPIES
6.2 THERAPY RECOMMENDATION, 2015 (%)
6.3 QUALITATIVE ASSESSMENT
7. CHOLESTEROL TESTING/CHOLESTEROL SCREENING SERVICES MARKET, BY TYPE OF CUSTOMER
7.1 PHYSICIANS/PROVIDERS AND HOSPITALS
7.2 EMPLOYERS, HEALTH PLANS, AND MANAGED CARE ORGANIZATIONS (MCOS)
7.3 GOVERNMENT AGENCIES, ACCOUNTable CARE ORGANIZATIONS, AND INTEGRATED DELIVERY NETWORKS (IDNS)
7.4 PATIENTS
8 . REGIONAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.2.2 CANADA
8.3 EUROPE
8.3.1 U.K.
8.3.2 GERMANY
8.3.3 FRANCE
8.3.4 ITALY
8.3.5 SPAIN
8.3.6 REST OF EUROPE
8.4 ASIA
8.5 REST OF THE WORLD
9. COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 MARKET SHARE ANALYSIS
9.3 COMPETITIVE SITUATION AND TRENDS
9.3.1 ACQUISITIONS
9.3.2 EXPANSIONS AND INVESTMENTS
9.3.3 AGREEMENTS
9.3.4 SERVICE LAUNCHES
10. COMPANY PROFILES
10.1 LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
10.2 QUEST DIAGNOSTICS INCORPORATED
10.3 EUROFINS SCIENTIFIC
10.4 SPECTRA LABORATORIES, INC.
10.5 UNILABS
10.6 SYNLAB INTERNATIONAL GMBH
10.7 BIO-REFERENCE LABORATORIES, INC.
10.8 CLINICAL REFERENCE LABORATORY, INC.
10.9 ACM MEDICAL LABORATORY)
10.10 ADICON CLINICAL LABORATORY
11. APPENDIX
11.1 KEY INDUSTRY INSIGHTS
11.2 DISCUSSION GUIDE
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
11.5 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET INTRODUCTION
1.3 MARKET DEFINITION
1.4 MARKET SCOPE
1.5 YEARS CONSIDERED FOR THE STUDY
1.6 LIMITATIONS
1.7 STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3 KEY DATA FROM SECONDARY SOURCES
2.4 KEY DATA FROM PRIMARY SOURCES
2.5 ASSUMPTIONS
3. EXECUTIVE SUMMARY
4. PREMIUM INSIGHTS
4.1 MARKET OVERVIEW
4.2 CHOLESTEROL TESTING SERVICES MARKET, BY TYPE OF CUSTOMER
4.3 GEOGRAPHIC SNAPSHOT: CHOLESTEROL TESTING SERVICES MARKET
5. INDUSTRY INSIGHTS
5.1 COST STRUCTURE & PRICING ANALYSIS
5.2 REIMBURSEMENT SCENARIO
6. MARKET DYNAMICS
6.1 INTRODUCTION
6.2 MARKET DRIVERS
6.2.1 Increasing incidence of cardiovascular diseases (CVDs) and obesity
6.2.2 Physician’s preference for lab testing over self-testing
6.2.3 Growing awareness and adoption of preventive healthcare
6.2.4 Government initiatives to improve quality of testing
6.2.5 Rapid growth in the geriatric population
6.2 MARKET RESTRAINTS
6.3.1 Rapidly growing cholesterol home/self-testing market
6.3.2 Emergence of noninvasive cholesterol testing methods
6.3 MARKET OPPORTUNITIES
6.4.1 High growth potential in emerging economies
6.4.2 Patient-initiated testing to foster market growth in developed countries
6.4 MARKET CHALLENGES
6.5.1 Patient data security
6.5.2 Evolving regulatory policies
7. NON-PHARMACOLOGICAL TREATMENT MARKET
6.1 INTRODUCTION
6.1.1 COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA (CBTI)
6.1.2 HYPNOTHERAPY
6.1.3 OTHER ALTERNATIVE THERAPIES
6.2 THERAPY RECOMMENDATION, 2015 (%)
6.3 QUALITATIVE ASSESSMENT
7. CHOLESTEROL TESTING/CHOLESTEROL SCREENING SERVICES MARKET, BY TYPE OF CUSTOMER
7.1 PHYSICIANS/PROVIDERS AND HOSPITALS
7.2 EMPLOYERS, HEALTH PLANS, AND MANAGED CARE ORGANIZATIONS (MCOS)
7.3 GOVERNMENT AGENCIES, ACCOUNTable CARE ORGANIZATIONS, AND INTEGRATED DELIVERY NETWORKS (IDNS)
7.4 PATIENTS
8 . REGIONAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.2.2 CANADA
8.3 EUROPE
8.3.1 U.K.
8.3.2 GERMANY
8.3.3 FRANCE
8.3.4 ITALY
8.3.5 SPAIN
8.3.6 REST OF EUROPE
8.4 ASIA
8.5 REST OF THE WORLD
9. COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 MARKET SHARE ANALYSIS
9.3 COMPETITIVE SITUATION AND TRENDS
9.3.1 ACQUISITIONS
9.3.2 EXPANSIONS AND INVESTMENTS
9.3.3 AGREEMENTS
9.3.4 SERVICE LAUNCHES
10. COMPANY PROFILES
10.1 LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
10.2 QUEST DIAGNOSTICS INCORPORATED
10.3 EUROFINS SCIENTIFIC
10.4 SPECTRA LABORATORIES, INC.
10.5 UNILABS
10.6 SYNLAB INTERNATIONAL GMBH
10.7 BIO-REFERENCE LABORATORIES, INC.
10.8 CLINICAL REFERENCE LABORATORY, INC.
10.9 ACM MEDICAL LABORATORY)
10.10 ADICON CLINICAL LABORATORY
11. APPENDIX
11.1 KEY INDUSTRY INSIGHTS
11.2 DISCUSSION GUIDE
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
11.5 RELATED REPORTS
LIST OF TABLES
Table 1 CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 2 CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY PHYSICIANS/PROVIDERS, BY REGION, 2014–2021 (USD MILLION)
Table 3 NORTH AMERICA: CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY PHYSICIANS/PROVIDERS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 4 EUROPE: CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY PHYSICIANS/PROVIDERS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 5 CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY EMPLOYERS, HEALTH PLANS, AND MCOS, BY REGION, 2014–2021 (USD MILLION)
Table 6 NORTH AMERICA: CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY EMPLOYERS, HEALTH PLANS, AND MCOS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 7 EUROPE: CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY EMPLOYERS, HEALTH PLANS, AND MCOS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 8 CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY GOVERNMENT AGENCIES, ACOS, AND IDNS, BY REGION, 2014–2021 (USD MILLION)
Table 9 NORTH AMERICA: CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY GOVERNMENT AGENCIES, ACOS, AND IDNS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 10 EUROPE: CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY GOVERNMENT AGENCIES, ACOS, AND IDNS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 11 PATIENT-DRIVEN CHOLESTEROL TESTING SERVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 12 NORTH AMERICA: PATIENT-DRIVEN CHOLESTEROL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 13 EUROPE: PATIENT-DRIVEN CHOLESTEROL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 14 GLOBAL CHOLESTEROL TESTING SERVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 15 NORTH AMERICA: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 16 NORTH AMERICA: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 17 U.S.: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 18 CANADA: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 19 EUROPE: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 20 EUROPE: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 21 U.K.: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 22 GERMANY: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 23 FRANCE: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 24 ITALY: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 25 SPAIN: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 26 ROE: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 27 ASIA: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 28 ROW: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 29 INDICATIVE LIST OF OTHER CHOLESTEROL TESTING SERVICE PROVIDERS
Table 30 ACQUISITIONS (2013–2016)
Table 31 EXPANSIONS AND INVESTMENTS (2013–2016)
Table 32 AGREEMENTS (2013-2016)
Table 33 SERVICE LAUNCHES (2013-2016)
Table 1 CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 2 CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY PHYSICIANS/PROVIDERS, BY REGION, 2014–2021 (USD MILLION)
Table 3 NORTH AMERICA: CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY PHYSICIANS/PROVIDERS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 4 EUROPE: CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY PHYSICIANS/PROVIDERS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 5 CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY EMPLOYERS, HEALTH PLANS, AND MCOS, BY REGION, 2014–2021 (USD MILLION)
Table 6 NORTH AMERICA: CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY EMPLOYERS, HEALTH PLANS, AND MCOS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 7 EUROPE: CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY EMPLOYERS, HEALTH PLANS, AND MCOS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 8 CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY GOVERNMENT AGENCIES, ACOS, AND IDNS, BY REGION, 2014–2021 (USD MILLION)
Table 9 NORTH AMERICA: CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY GOVERNMENT AGENCIES, ACOS, AND IDNS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 10 EUROPE: CHOLESTEROL TESTING SERVICES MARKET SIZE FOR TESTS REFERRED BY GOVERNMENT AGENCIES, ACOS, AND IDNS, BY COUNTRY, 2014–2021 (USD MILLION)
Table 11 PATIENT-DRIVEN CHOLESTEROL TESTING SERVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 12 NORTH AMERICA: PATIENT-DRIVEN CHOLESTEROL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 13 EUROPE: PATIENT-DRIVEN CHOLESTEROL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 14 GLOBAL CHOLESTEROL TESTING SERVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 15 NORTH AMERICA: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 16 NORTH AMERICA: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 17 U.S.: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 18 CANADA: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 19 EUROPE: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 20 EUROPE: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 21 U.K.: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 22 GERMANY: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 23 FRANCE: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 24 ITALY: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 25 SPAIN: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 26 ROE: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 27 ASIA: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 28 ROW: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014–2021 (USD MILLION)
Table 29 INDICATIVE LIST OF OTHER CHOLESTEROL TESTING SERVICE PROVIDERS
Table 30 ACQUISITIONS (2013–2016)
Table 31 EXPANSIONS AND INVESTMENTS (2013–2016)
Table 32 AGREEMENTS (2013-2016)
Table 33 SERVICE LAUNCHES (2013-2016)
LIST OF FIGURES
Figure 1 SEGMENTATION & COVERAGE
Figure 2 RESEARCH DESIGN
Figure 3 CHOLESTEROL TESTING SERVICES MARKET - BOTTOM UP APPROACH
Figure 4 CHOLESTEROL TESTING SERVICES MARKET - TOP DOWN APPROACH
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2016 VS. 2021
Figure 7 GEOGRAPHICAL SNAPSHOT OF THE CHOLESTEROL TESTING SERVICES MARKET: ASIA TO WITNESS THE HIGHEST CAGR FROM 2016 TO 2021
Figure 8 INCREASING INCIDENCE OF CARDIOVASCULAR DISEASES AND OBESITY: MAJOR FACTOR DRIVING THE GROWTH OF THE CHOLESTEROL TESTING SERVICES MARKET
Figure 9 PHYSICIANS/PROVIDERS AND HOSPITALS SEGMENT TO DOMINATE THE MARKET IN 2016
Figure 10 GEOGRAPHIC GROWTH OPPORTUNITIES: ASIA TO WITNESS THE HIGHEST CAGR IN THE CHOLESTEROL TESTING SERVICES MARKET FROM 2016 TO 2021
Figure 11 PRICING ANALYSIS
Figure 12 CHOLESTEROL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 13 KEY DEVELOPMENTS IN THE CHOLESTEROL TESTING MARKET, 2013–2016
Figure 14 GLOBAL CHOLESTEROL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2015
Figure 15 ACQUISITIONS ACCOUNTED FOR THE LARGEST SHARE OF THE TOTAL DEVELOPMENTS IN THE CHOLESTEROL TESTING SERVICES MARKET (2013–2016)
Figure 16 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2015)
Figure 17 QUEST DIAGNOSTICS INCORPORATED: COMPANY SNAPSHOT (2015)
Figure 18 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2015)
Figure 19 FRESENIUS MEDICAL CARE: COMPANY SNAPSHOT (2015)
Figure 20 OPKO HEALTH, INC.: COMPANY SNAPSHOT (2015)
Figure 21 INSIGHTS FROM INDUSTRY EXPERTS
Figure 1 SEGMENTATION & COVERAGE
Figure 2 RESEARCH DESIGN
Figure 3 CHOLESTEROL TESTING SERVICES MARKET - BOTTOM UP APPROACH
Figure 4 CHOLESTEROL TESTING SERVICES MARKET - TOP DOWN APPROACH
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2016 VS. 2021
Figure 7 GEOGRAPHICAL SNAPSHOT OF THE CHOLESTEROL TESTING SERVICES MARKET: ASIA TO WITNESS THE HIGHEST CAGR FROM 2016 TO 2021
Figure 8 INCREASING INCIDENCE OF CARDIOVASCULAR DISEASES AND OBESITY: MAJOR FACTOR DRIVING THE GROWTH OF THE CHOLESTEROL TESTING SERVICES MARKET
Figure 9 PHYSICIANS/PROVIDERS AND HOSPITALS SEGMENT TO DOMINATE THE MARKET IN 2016
Figure 10 GEOGRAPHIC GROWTH OPPORTUNITIES: ASIA TO WITNESS THE HIGHEST CAGR IN THE CHOLESTEROL TESTING SERVICES MARKET FROM 2016 TO 2021
Figure 11 PRICING ANALYSIS
Figure 12 CHOLESTEROL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 13 KEY DEVELOPMENTS IN THE CHOLESTEROL TESTING MARKET, 2013–2016
Figure 14 GLOBAL CHOLESTEROL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2015
Figure 15 ACQUISITIONS ACCOUNTED FOR THE LARGEST SHARE OF THE TOTAL DEVELOPMENTS IN THE CHOLESTEROL TESTING SERVICES MARKET (2013–2016)
Figure 16 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2015)
Figure 17 QUEST DIAGNOSTICS INCORPORATED: COMPANY SNAPSHOT (2015)
Figure 18 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2015)
Figure 19 FRESENIUS MEDICAL CARE: COMPANY SNAPSHOT (2015)
Figure 20 OPKO HEALTH, INC.: COMPANY SNAPSHOT (2015)
Figure 21 INSIGHTS FROM INDUSTRY EXPERTS
